in the previous review, steady infusions of copyright were being safely administered for up to 90?min (Gouzoulis-Mayfrank et al., 2005) and the infusion rates had been described to be determined through a former pilot research with 6 subjects. However, this report lacked information on how potent and sustained these consequences were being with tim